Current Issues in Molecular Biology,
Journal Year:
2024,
Volume and Issue:
46(5), P. 4471 - 4488
Published: May 8, 2024
The
correlation
between
neurodegenerative
diseases
and
the
gut
microbiome
is
increasingly
evident,
with
amyotrophic
lateral
sclerosis
(ALS)
being
particularly
notable
for
its
severity
lack
of
therapeutic
options.
microbiota,
implicated
in
pathogenesis
development
ALS,
plays
a
crucial
role
disease.
Bioactive
plant
molecules,
specifically
volatile
compounds
essential
oils,
offer
promising
avenue
due
to
their
anti-inflammatory
properties
gut-modulating
effects.
Our
narrative
review
aimed
identify
microbiota-associated
bacteria
ALS
analyze
benefits
administering
bioactive
molecules
as
much-needed
options
management
this
A
comprehensive
search
PubMed
database
articles
published
before
December
2023,
encompassing
research
on
cell,
human,
animal
models,
was
conducted.
After
selecting,
analyzing,
discussing
key
articles,
linked
physiopathology
were
identified.
Notably,
positively
highlighted
included
Akkermansia
muciniphila
(Verrucomicrobia
phylum),
Faecalibacterium
prausnitzii,
Butyrivibrio
spp.
(Firmicutes
phylum).
Conversely,
members
Escherichia
coli
(Proteobacteria
phylum)
Ruminococcus
stood
out
negatively
respect
development.
These
associated
molecular
changes
evolution.
can
be
directly
improvements
microbiome,
reducing
inflammation
oxidative
stress,
emerging
one
most
natural
agents
enriching
present-day
treatments.
Frontiers in Pharmacology,
Journal Year:
2025,
Volume and Issue:
16
Published: April 23, 2025
This
study
aims
to
elucidate
the
mitigating
effects
of
volatile
oil
Acori
tatarinowii
rhizoma
(ATR)
on
dementia,
in
order
provide
a
reference
for
future
research
and
applications
ATR
field
dementia.
A
search
strategy
was
developed
using
terms
such
as
"Acori
rhizoma,"
"Acorus
Schott,"
"Asarone,"
"Dementia."
The
literature
conducted
PubMed,
Web
Science,
Google
Scholar,
studies
not
meeting
inclusion
criteria
were
excluded.
summarizes
main
metabolites,
active
ingredients,
toxicological
properties,
pharmacokinetic
characteristics
from
with
particular
focus
its
potential
mechanisms
action.
Furthermore,
highlights
limitations
existing
offers
insights
into
directions.
mitigates
dementia
through
multiple
pathways,
including
reducing
abnormal
protein
aggregation,
promoting
neurogenesis,
inhibiting
neuronal
apoptosis,
regulating
neurotransmitters,
improving
synaptic
function,
modulating
autophagy,
countering
cellular
stress,
neuroinflammation,
alleviating
vascular
risk
factors.
multi-pathway
pharmacological
are
well-aligned
complex
progression,
highlighting
significant
therapeutic
anti-dementia
applications.
provides
new
perspectives
development
more
effective
drugs.
Nonetheless,
further
rigorous
high-quality
preclinical
clinical
investigations
required
address
key
issues,
chemical
characterization
ATR,
synergistic
among
toxicity
profiles,
definitive
efficacy.
Frontiers in Pharmacology,
Journal Year:
2025,
Volume and Issue:
16
Published: April 25, 2025
Alzheimer's
disease
(AD)
is
a
degenerative
of
the
central
nervous
system
characterized
by
progressive
cognitive
impairment
and
memory
loss.
Chinese
medicine's
therapeutic
effect
on
AD
has
become
promising
treatment
option
in
recent
years,
herbal
compound
Kai
Xin
San-Jia
Wei
(KXSJW)
one
its
representatives.
This
study
employed
comprehensive
approach,
including
16S
rRNA
Gaschromatography-mass
spectrometry
(GC-MS)
analysis,
to
investigate
efficacy
intrinsic
mechanism
KXSJW
AD.
50
3-month-old
APPswe/PS1dE9
transgenic
mice
were
randomly
divided
into
5
groups
(n
=
10):
model
group
(M),
donepezil
(Don),
KXSJW-low
dose
(KJW-L),
KXSJW-
medium
(KJW-M),
KXSJW-high
(KJW-H),
Ten
C57BL/6
J
wild-type
selected
as
control
(C).
The
administered
saline
gavage,
was
(0.92
mg/kg/d),
KXSJW-low/medium/high
extract
(0.9/1.8/3.6
mL/kg/d);
each
treated
once
daily
for
2
months.
Morris
Water
Maze
(MWM)
evaluate
learning
abilities.
Pathological
changes
colon
tissue
assessed
through
hematoxylin
eosin
(HE)
staining.
Analysis
gut
microbiota
conducted
using
sequencing,
microbial
metabolite
(short
chain
fatty
acids,
SCFAs)
content
detected
GC-MS.
Colonic
barrier
integrity
examined
immunohistochemistry
western
blot,
while
β-amyloid
deposition
brain
assessed.
ELISA
used
measure
serum
intestinal
peptide
hormones
(Glucagon,
GHRP-Ghrelin).
enhanced
ability
memory,
reduced
amyloid
mice.
able
restore
balance
flora
regulate
concentration
metabolites,
especially
represented
Firmicutes
major
butyric
acid.
Meanwhile,
restored
function
improved
release
level
GHRP-Ghrelin)
indicates
that
can
improve
internal
environment
may
homeostasis
AD,
with
focus
regulation
microorganisms
their
subsequently
Traditional
Medicine
(TCM)
potential
intervene
multilevel
interaction
brain-gut-axis.
Biology,
Journal Year:
2025,
Volume and Issue:
14(5), P. 488 - 488
Published: April 29, 2025
As
a
phytotherapeutic
agent
with
historical
applications
in
epilepsy
management,
Acorus
tatarinowii
Schott
(ATS)
remains
pharmacologically
enigmatic,
particularly
regarding
its
pathophysiological
mechanisms.
This
knowledge
gap
significantly
hinders
the
clinical
application
of
ATS-based
treatments.
To
explore
potential
ATS
combating
epileptogenesis,
we
utilized
pentylenetetrazole
(PTZ)-induced
chronic
rat
model.
Brain
metabolomic
analysis
was
performed
by
ultra-performance
liquid
chromatography
coupled
mass
spectrometry
(UPLC/MS).
Principal
component
(PCA)
and
orthogonal
projections
to
latent
structures-discriminant
(OPLS-DA)
were
for
screening
differential
metabolites.
Gut
microbiota
composition
analyzed
through
16S
rRNA
gene
sequencing
examined
using
Spearman
correlation
analysis.
The
results
show
that
oral
(50
mg/kg)
improved
seizure
latency
pathology
rats
epilepsy.
Ascorbate
aldarate
metabolism,
glycerophospholipid
arachidonic
acid
intestinal
flora
crucial
ATS’s
ability
counteract
therapeutic
effects
against
investigated
brain
metabolomics
gut
analysis,
providing
basis
further
comprehensive
research.
RSC Medicinal Chemistry,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Jan. 1, 2024
Alzheimer's
disease
(AD)
is
a
prevalent
degenerative
disorder
affecting
the
central
nervous
system
of
elderly.
Patients
primarily
manifest
cognitive
decline
and
non-cognitive
neuro-psychiatric
symptoms.
Currently,
western
medications
for
AD
include
cholinesterase
inhibitors
glutamate
receptor
inhibitors,
which
have
limited
efficacy
accompanied
by
significant
toxic
side
effects.
Given
intricate
pathogenesis
AD,
use
single-target
limited.
In
recent
years,
as
research
on
has
progressed,
traditional
Chinese
medicine
(TCM)
its
active
ingredients
increasingly
played
crucial
role
in
clinical
treatment.
Numerous
studies
demonstrate
that
TCM
can
exert
anti-Alzheimer's
effects
modulating
pathological
protein
production
deposition,
inhibiting
tau
hyperphosphorylation,
apoptosis,
inflammation,
oxidative
stress,
while
enhancing
cholinergic
system,
protecting
neurons
synapses,
optimizing
energy
metabolism.
This
article
summarizes
extracts
from
briefly
elucidates
their
pharmacological
mechanisms
against
aiming
to
provide
foundation
further
into
specific
prevention
treatment
disease,
well
identification
efficacious
ingredients.
Natural Products and Bioprospecting,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: Feb. 26, 2024
Neurodegenerative
diseases
(NDs)
are
common
chronic
arising
from
progressive
damage
to
the
nervous
system.
Here,
in-house
natural
product
database
screening
revealed
that
libertellenone
C
(LC)
obtained
fermentation
products
of
Arthrinium
arundinis
separated
gut
a
centipede
collected
in
our
Tongji
campus,
showed
remarkable
neuroprotective
effect.
Further
investigation
was
conducted
clarify
specific
mechanism.
LC
dose-dependently
reversed
glutamate-induced
decreased
viability,
accumulated
reactive
oxygen
species,
mitochondrial
membrane
potential
loss,
and
apoptosis
SH-SY5Y
cells.
Network
pharmacology
analysis
predicted
targets
were
most
likely
directly
related
oxidative
stress
regulation
inflammatory
factor-associated
signaling
pathways.
study
demonstrated
attenuated
nitrite,
TNF-α,
IL-1β
production
inducible
nitric
oxide
synthase
cyclooxygenase
expression
lipopolysaccharide-induced
BV-2
could
inhibit
NLRP3
inflammasome
activation
by
decreasing
levels
NLRP3,
ASC,
cleaved
Caspase-1,
NF-κB
p65.
Our
results
provide
new
understanding
how
inhibits
microglia,
providing
neuroprotection.
These
findings
might
guide
development
effective
LC-based
therapeutic
strategies
for
NDs.
Frontiers in Pharmacology,
Journal Year:
2024,
Volume and Issue:
15
Published: July 26, 2024
Abnormal
glucose
metabolism
in
microglial
is
closely
associated
with
Alzheimer's
disease
(AD).
Reprogramming
of
centered
on
regulating
the
way
which
metabolize
to
alter
function.
Therefore,
reprogramming
considered
as
a
therapeutic
strategy
for
AD.
Huanshaodan
(HSD)
Chinese
herbal
compound
shows
significant
efficacy
treating
AD,
however,
precise
mechanism
by
HSD
treats
AD
remains
unclear.
This
study
aim
investigate
whether
exerts
anti-AD
effects
metabolic
through
mTOR/HIF-1α
signaling
pathway.
SAMP8
mice
and
BV2
cells
were
used
explore
alleviative
effect
molecular